Pathophysiology of Diabetic Dyslipidemia

Journal of Atherosclerosis and Thrombosis
Tsutomu Hirano

Abstract

Accumulating clinical evidence has suggested serum triglyceride (TG) is a leading predictor of atherosclerotic cardiovascular disease, comparable to low-density lipoprotein (LDL)-cholesterol (C) in populations with type 2 diabetes, which exceeds the predictive power of hemoglobinA1c. Atherogenic dyslipidemia in diabetes consists of elevated serum concentrations of TG-rich lipoproteins (TRLs), a high prevalence of small dense low-density lipoprotein (LDL), and low concentrations of cholesterol-rich high-density lipoprotein (HDL)2-C. A central lipoprotein abnormality is an increase in large TG-rich very-low-density lipoprotein (VLDL)1, and other lipoprotein abnormalities are metabolically linked to increased TRLs. Insulin critically regulates serum VLDL concentrations by suppressing hepatic VLDL production and stimulating VLDL removal by activation of lipoprotein lipase. It is still debated whether hyperinsulinemia compensatory for insulin resistance is causally associated with the overproduction of VLDL. This review introduces experimental and clinical observations revealing that insulin resistance, but not hyperinsulinemia stimulates hepatic VLDL production. LDL and HDL consist of heterogeneous particles with different size and...Continue Reading

References

Sep 1, 1979·Circulation·D B Zilversmit
Dec 16, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·S P ZhaoA van der Laarse
Dec 1, 1986·Metabolism: Clinical and Experimental·C E SparksJ M Amatruda
Feb 23, 1967·The New England Journal of Medicine·J D BagdadeE L Bierman
Jan 1, 1981·Diabetes·G M Reaven, M S Greenfield
Jul 1, 1982·The Journal of Clinical Investigation·P N DurringtonD Steinberg
Nov 1, 1980·The American Journal of Physiology·J MelishW V Brown
Oct 1, 1994·The American Journal of Physiology·G F LewisG Steiner
Dec 31, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·K NakajimaE Campos
May 13, 1994·Biochimica Et Biophysica Acta·Z Yao, R S McLeod
Sep 18, 1996·JAMA : the Journal of the American Medical Association·M J StampferC H Hennekens
Jul 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·R MalmströmM R Taskinen
Dec 16, 1998·Diabetes Care·R C Turner
Sep 12, 2001·American Journal of Physiology. Endocrinology and Metabolism·T HiranoM Adachi
Sep 18, 2002·Journal of Lipid Research·Kaspar K Berneis, Ronald M Krauss
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Len A Pennacchio, Edward M Rubin
May 7, 2003·Biochemical and Biophysical Research Communications·Haruaki KageyamaMitsuru Adachi
Aug 5, 2003·Journal of Lipid Research·Tsutomu HiranoGen Yoshino
Oct 18, 2003·Metabolism: Clinical and Experimental·Toshihiro TakahashiMitsuru Adachi
Jan 17, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Tsutomu HiranoGen Yoshino
May 10, 2005·The Journal of Biological Chemistry·Aivar LookeneRobert O Ryan
Feb 2, 2006·The Journal of Clinical Endocrinology and Metabolism·Brian R Barrows, Elizabeth J Parks

❮ Previous
Next ❯

Citations

Feb 7, 2019·Journal of Atherosclerosis and Thrombosis·Hung HsuMasumi Ai
Jul 28, 2019·Current Opinion in Lipidology·Masato Kajikawa, Yukihito Higashi
Aug 11, 2020·Current Opinion in Endocrinology, Diabetes, and Obesity·Blair J O'Neill
Mar 5, 2020·Reviews in Endocrine & Metabolic Disorders·Jacob Bar-Tana
Apr 25, 2020·Journal of Nephrology·Giuseppina RussoSalvatore De Cosmo
Dec 19, 2018·International Journal of Molecular Sciences·Stella BernardiBruno Fabris
Aug 14, 2020·Biological Trace Element Research·Cristhian Neftaly Sánchez-SolísSamuel Treviño
Mar 12, 2020·International Journal of Molecular Sciences·Anastasia PoznyakAlexander N Orekhov
Nov 30, 2019·Frontiers in Endocrinology·Saarah Fatoma DavidsAndre Pascal Kengne
Feb 26, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Yuhong DuanChunguang Xie
Oct 25, 2020·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Gulay Simsek Bagirİlknur Kozanoglu
Dec 31, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Izabela Tuleta, Nikolaos G Frangogiannis
Sep 24, 2019·Neuroscience and Biobehavioral Reviews·Gerwyn MorrisMichael Berk
Feb 2, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Mohammad AlmariAli H Ziyab
Feb 4, 2021·International Journal of Molecular Sciences·Hiroshi Kitamura, Mayuko Hashimoto
Oct 31, 2019·Global Health & Medicine·Hidekatsu YanaiHiroshi Yoshida
Dec 5, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Kassahun Haile, Abebe Timerga
Feb 24, 2021·The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology·Hesham Salah El Din TahaMirna Mamdouh Shaker
Feb 23, 2021·Journal of Nutritional Science and Vitaminology· Fatmah
Mar 8, 2021·Molecular Biology Reports·Xin Su
Jul 18, 2020·Archives of Biochemistry and Biophysics·Eleonora CremoniniPatricia I Oteiza
Jun 3, 2020·Advanced Drug Delivery Reviews·Kerstin StemmerTimo D Müller
May 5, 2021·Toxicology Mechanisms and Methods·Ramasamy Chandramohan, Leelavinothan Pari

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

Journal of Atherosclerosis and Thrombosis
Chris J Packard, Yasushi Saito
Rinsho byori. The Japanese journal of clinical pathology
Tsutomu Hirano
© 2022 Meta ULC. All rights reserved